Exelixis Inc. buy Royal Bank of Canada
Start price
14.05.25
/
50%
€39.53
Target price
14.05.26
€35.75
Performance (%)
-4.14%
Price
08.04.26
€37.90
Summary
This prediction is currently active. With a performance of -4.14%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 14.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Exelixis Inc. | -0.303% | -0.303% |
| iShares Core DAX® | 3.011% | 1.442% |
| iShares Nasdaq 100 | 3.009% | 0.574% |
| iShares Nikkei 225® | 4.142% | 4.547% |
| iShares S&P 500 | 2.378% | 0.244% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $40.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat